Advances in drug design of radiometal-based imaging agents for bone disorders.
about
Contemporary approaches for imaging skeletal metastasisDevelopment of novel radiogallium-labeled bone imaging agents using oligo-aspartic acid peptides as carriersOn the Reaction of Carbonyl Diphosphonic Acid with Hydroxylamine and O-alkylhydroxylamines: Unexpected Degradation of P-C-P Bridge.Evaluation of Ga-DOTA-(D-Asp)n as bone imaging agents: D-aspartic acid peptides as carriers to bone.Synthesis and evaluation of a novel 99m Tc nitrido radiopharmaceutical with alendronate dithiocarbamate as a potential bone-imaging agent.
P2860
Advances in drug design of radiometal-based imaging agents for bone disorders.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Advances in drug design of radiometal-based imaging agents for bone disorders.
@en
type
label
Advances in drug design of radiometal-based imaging agents for bone disorders.
@en
prefLabel
Advances in drug design of radiometal-based imaging agents for bone disorders.
@en
P2860
P356
P1476
Advances in drug design of radiometal-based imaging agents for bone disorders.
@en
P2093
Hideo Saji
Kazuma Ogawa
P2860
P304
P356
10.1155/2011/537687
P577
2011-12-15T00:00:00Z